Model Can Predict Patient Outcomes to Immunotherapy, Engineer Proper Regimens
A clinically applicable mathematical model was developed by researchers to predict outcomes to immunotherapy for patients with cancer previously treated with anti –CTLA-4 or anti–PD-1/PD-L1 antibodies.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news